US Overdose Deaths Drop for Third Year

Preliminary federal data indicates a third consecutive annual drop in U.S. overdose deaths, marking the longest decline in decades and bringing figures back to pre-pandemic levels of 2019. The Centers for Disease Control and Prevention reported decreases across various drug types, though Arizona, Colorado, and New Mexico saw increases.

Experts express cautious optimism but warn of a precarious balance, noting that deaths could rise rapidly if efforts falter. The decline follows a pandemic-era surge, with factors like increased naloxone access, expanded treatment, and changes in drug supply contributing to the positive trend.

Despite this progress, health officials are alarmed by new, potent substances entering the drug supply, with 23 identified so far in 2026. Cyclorphine, an opioid up to 10 times stronger than fentanyl, is a particular concern. Concurrently, policy changes are shifting away from harm reduction services.

Critics, including parents who lost children to overdoses, argue that these policy shifts, such as defunding test strips and kits, undermine vital harm reduction efforts that have contributed to the declining death rates. They advocate for continued support for services like clean syringes and hotlines.